2002 · 11 citations · 13 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug MetabolismEnzymologyAntimetabolite TherapyDrug-metabolizing EnzymesEnzyme InhibitionEnzyme KineticsEnzyme TargetsAmino AcidsAnticancer ActivityAnticancer ChemotherapyAntimetabolite Mechanisms Of ActionCompetitive InhibitionEnzyme Reaction MechanismsPolyamine BiosynthesisPyrimidine Analogues
,Summary. Enzymes catalyze virtually every biochemical process in the cell. The usefulness of the most important pharmaceutical agents, antimetabolites, is based on the concept of competitive enzyme inhibition. The antimetabolites are structural analogues of normal biochemical compounds. As competitive inhibitors they compete with the naturally substrate for the active site of enzyme and block the formation of undesirable metabolic products in the body. Antibacterial, antiviral and anticancer pharmaceutical agents are among numerous examples of antimetabolites. Sulfa drags, sulfanilamide, structural analogs of amino acids (cycloserine, L-fluoroalanine), folic acid antagonists (4amino-10-methyl folic acid=methotrexate), analogues of purine and pyrimidine (6-mercaptopurine, allopurinol, 5fluorouracil, 5-azacytidine), inhibitors of polyamine biosynthesis (difluoromethyl ornithine, methylglyoxal-bis (guanyl hydrazone)) are the most used in modern chemotherapy The use of enzyme inhibitors, antimetabolites, beside the therapeutic significance has also provided valuable informations about enzyme mechanisms and has helped to define some metabolic pathways.
13
Biochemical Education · 1978 · 5.1K citations
Annals of Internal Medicine · 1985 · 2.1K citations
Polyamines in Normal and Neoplastic Growth
Peter O’Connor · British Journal of Cancer · 1976 · 550 citations · Full text
Frank M. Balis, John S. Holcenberg, David G. Poplack et al. · Blood · 1998 · 112 citations